Systematic review of guideline-recommended medications prescribed for treatment of low back pain

Table 6 CPG AGREE II domain scores and quality assessments reported as percentage

Title	1. Scope and Purpose	2. Stakeholder Involvement	3. Rigour of development	4. Clarity of Presentation	5. Applicability	6. Editorial Independence	Overall Assessment	Quality (High/Low)
ACP [66]	95	92	98	95	88	100	96	High
DHA [72]	94	88	99	92	52	98	86	High
GSCI [60]	94	86	77	96	88	100	89	High
ICSI [69]	96	98	86	99	87	95	86	High
KCE [70]	99	100	99	98	93	100	96	High
NASS [68]	100	100	95	89	71	100	96	High
NICE [71]	100	99	99	98	99	100	100	High
TOP [73]	80	48	53	100	64	29	71	Low
VA/DoD [67]	95	95	88	98	82	100	96	High

ACP, American College of Physicians; DHA, Danish Health Authority; GSCI, Global Spine Care Initiative; ICSI, Institute of Clinical Systems Improvement; KCE, Belgian Health Care Knowledge Centre; NASS, North American Spine Society; NGC, National Guideline Centre; NICE, National Institute for Health and Care Excellence; TOP, Toward Optimized Practice; VA/DoD, Veterans Affairs/Department of Defense

ISSN: 2045-709X